Updated:
Telegraph Hill Partners
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives.
Telegraph Hill Partners
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. It partners with private life science and healthcare companies that have novel technologies, a solid customer base, and innovative management teams, providing capital and strategic guidance.
General information
Firm type
Private Equity
Year founded
2001
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Deval A. Lashkari
Ph.D., Senior Partner
Rob C. Hart
J.D., CFA, Partner
Gary D. Curtis
Senior Advisor
Anthony Manupella
Controller
Sector focus
Frequently asked questions
Does Telegraph Hill Partners participate in fund commitments or only direct deals?
All publicly available information describes direct investment activity — growth equity rounds, management buyouts, and founder liquidity deals — with no mention of fund-of-fund commitments or allocations to external managers. The firm's strategy page emphasizes being the lead or sole institutional investor, reinforcing a direct-only approach.
How is Telegraph Hill Partners structured — does it operate more like a venture firm or a traditional buyout shop?
The firm occupies a hybrid position: it writes equity checks into revenue-stage companies, resembling growth equity, but also pursues management buyouts and corporate carve-outs, which are hallmarks of traditional private equity. This dual capability, confined to a single sector vertical, differentiates it from both generalist venture firms and multi-sector mid-market buyout funds.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: